AVTR Quote, Financials, Valuation and Earnings

Bruker Corp. has a net margin of -43.84% compared to Avantor, Inc.'s net margin of -6.8%. Avantor, Inc.'s return on equity of -1.4% beat Bruker Corp.'s return on equity of -1.2%.

Avantor, Inc. has a consensus price target of $13.64, signalling upside risk potential of 20.84%. On the other hand Bruker Corp. has an analysts' consensus of $48.83 which suggests that it could grow by 2.03%. Given that Avantor, Inc. has higher upside potential than Bruker Corp., analysts believe Avantor, Inc. is more attractive than Bruker Corp..

Avantor, Inc. has a beta of 0.930, which suggesting that the stock is 7.02% less volatile than S&P 500. In comparison Bruker Corp. has a beta of 1.174, suggesting its more volatile than the S&P 500 by 17.405%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Bruker Corp. offers a yield of 0.42% to investors and pays a quarterly dividend of $0.05 per share. Avantor, Inc. pays -- of its earnings as a dividend. Bruker Corp. pays out 26.44% of its earnings as a dividend. Bruker Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avantor, Inc. quarterly revenues are $1.6B, which are larger than Bruker Corp. quarterly revenues of $860.5M. Avantor, Inc.'s net income of -$711.8M is lower than Bruker Corp.'s net income of -$58.5M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Bruker Corp.'s PE ratio is 77.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 1.17x versus 2.11x for Bruker Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Humana, Inc. has a net margin of -43.84% compared to Avantor, Inc.'s net margin of 0.59%. Avantor, Inc.'s return on equity of -1.4% beat Humana, Inc.'s return on equity of 7.3%.

Avantor, Inc. has a consensus price target of $13.64, signalling upside risk potential of 20.84%. On the other hand Humana, Inc. has an analysts' consensus of $287.08 which suggests that it could grow by 11.74%. Given that Avantor, Inc. has higher upside potential than Humana, Inc., analysts believe Avantor, Inc. is more attractive than Humana, Inc..

Avantor, Inc. has a beta of 0.930, which suggesting that the stock is 7.02% less volatile than S&P 500. In comparison Humana, Inc. has a beta of 0.462, suggesting its less volatile than the S&P 500 by 53.84%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humana, Inc. offers a yield of 1.38% to investors and pays a quarterly dividend of $0.89 per share. Avantor, Inc. pays -- of its earnings as a dividend. Humana, Inc. pays out 35.45% of its earnings as a dividend. Humana, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avantor, Inc. quarterly revenues are $1.6B, which are smaller than Humana, Inc. quarterly revenues of $32.6B. Avantor, Inc.'s net income of -$711.8M is lower than Humana, Inc.'s net income of $194M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Humana, Inc.'s PE ratio is 24.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 1.17x versus 0.25x for Humana, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Inspire Medical Systems, Inc. has a net margin of -43.84% compared to Avantor, Inc.'s net margin of 4.42%. Avantor, Inc.'s return on equity of -1.4% beat Inspire Medical Systems, Inc.'s return on equity of 6.62%.

Avantor, Inc. has a consensus price target of $13.64, signalling upside risk potential of 20.84%. On the other hand Inspire Medical Systems, Inc. has an analysts' consensus of $119.40 which suggests that it could fall by -11.39%. Given that Avantor, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Avantor, Inc. is more attractive than Inspire Medical Systems, Inc..

Avantor, Inc. has a beta of 0.930, which suggesting that the stock is 7.02% less volatile than S&P 500. In comparison Inspire Medical Systems, Inc. has a beta of 0.696, suggesting its less volatile than the S&P 500 by 30.412%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inspire Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Avantor, Inc. pays -- of its earnings as a dividend. Inspire Medical Systems, Inc. pays out -- of its earnings as a dividend.

Avantor, Inc. quarterly revenues are $1.6B, which are larger than Inspire Medical Systems, Inc. quarterly revenues of $224.5M. Avantor, Inc.'s net income of -$711.8M is lower than Inspire Medical Systems, Inc.'s net income of $9.9M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Inspire Medical Systems, Inc.'s PE ratio is 92.43x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 1.17x versus 4.59x for Inspire Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Revvity, Inc. has a net margin of -43.84% compared to Avantor, Inc.'s net margin of 6.76%. Avantor, Inc.'s return on equity of -1.4% beat Revvity, Inc.'s return on equity of 3.05%.

Avantor, Inc. has a consensus price target of $13.64, signalling upside risk potential of 20.84%. On the other hand Revvity, Inc. has an analysts' consensus of $113.67 which suggests that it could grow by 10.08%. Given that Avantor, Inc. has higher upside potential than Revvity, Inc., analysts believe Avantor, Inc. is more attractive than Revvity, Inc..

Avantor, Inc. has a beta of 0.930, which suggesting that the stock is 7.02% less volatile than S&P 500. In comparison Revvity, Inc. has a beta of 1.059, suggesting its more volatile than the S&P 500 by 5.937%.

Avantor, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Revvity, Inc. offers a yield of 0.27% to investors and pays a quarterly dividend of $0.07 per share. Avantor, Inc. pays -- of its earnings as a dividend. Revvity, Inc. pays out 11.63% of its earnings as a dividend. Revvity, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Avantor, Inc. quarterly revenues are $1.6B, which are larger than Revvity, Inc. quarterly revenues of $698.9M. Avantor, Inc.'s net income of -$711.8M is lower than Revvity, Inc.'s net income of $47.2M. Notably, Avantor, Inc.'s price-to-earnings ratio is 10.97x while Revvity, Inc.'s PE ratio is 51.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Avantor, Inc. is 1.17x versus 4.36x for Revvity, Inc.. Usually stocks with elevated PS ratios are considered overvalued.